Increase the efficiency of regulatory and medical writing with Certara’s purpose-built Generative AI-Enabled Writing Software.| Certara
Certara introduces Libra™, an AI-powered tool within ToxStudio® to predict drug-induced liver injury (DILI) early in discovery. Using QSAR modeling, Bayesian analytics, and automated reporting, Libra helps researchers improve drug safety, reduce late-stage failures, and align with FDA’s 2025 roadmap on New Approach Methodologies.| Certara
Meet DIDB Concomitant Meds Navigator—an evidence-based tool to identify contraindicated or monitored co-medications and manage DDI risk in clinical trials.| Certara